{"title":"预测内镜黏膜下剥离术可切除性的内镜超声分类:PREDICT 分类。","authors":"Noriko Matsuura, Motohiko Kato, Kentaro Iwata, Kurato Miyazaki, Teppei Masunaga, Yoko Kubosawa, Mari Mizutani, Yukie Hayashi, Kaoru Takabayashi, Yusaku Takatori, Atsushi Nakayama, Koji Okabayashi, Hirofumi Kawakubo, Yuko Kitagawa, Naohisa Yahagi","doi":"10.1055/a-2387-1754","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background and study aims</b> The safety of endoscopic submucosal dissection (ESD) has been reported, and the risk of lymph node metastasis is low for colorectal cancer if depth of invasion is the only non-curative factor on histological evaluation. ESD is increasingly performed even if submucosal (SM) invasion is suspected. However, reports about endoscopic findings for the criteria to predict ESD resectability remain limited. Endoscopic ultrasound (EUS) can directly visualize the tomographic image of the gastrointestinal wall and may help predict ESD resectability. Therefore, we investigated the possibility of predicting ESD resectability using EUS. <b>Patients and methods</b> We compared the association between EUS findings and pathological results for gastric or colorectal lesions with suspected SM invasion using white light endoscopy between June 2020 and January 2023. EUS findings were grouped based on the status of the underlying the tumor, as follows: Type I, submucosal layer was observed with reproducibility; Type II, submucosal layer not fully visible; and Type III, submucosal layer disrupted and muscularis propria (MP) layer thickened. <b>Results</b> Forty-one gastric cancer and 22 colorectal cancer cases were analyzed. The proportions of pathological VM0 (no tumor exposed on any vertical margin) for ESD-resected specimens were 89% and 33% for Type I and II, respectively, ( <i>P</i> ≤ 0.01). The proportions of cancer involving MP or deeper were significantly higher for Type II/III than for Type I (41% vs 0%, <i>P</i> ≤ 0.01). <b>Conclusions</b> EUS may have an important role in predicting ESD resectability of gastric and colorectal cancers suspected of having SM invasion.</p>","PeriodicalId":11671,"journal":{"name":"Endoscopy International Open","volume":"12 9","pages":"E1075-E1084"},"PeriodicalIF":2.2000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11405118/pdf/","citationCount":"0","resultStr":"{\"title\":\"Endoscopic ultrasound classification for prediction of endoscopic submucosal dissection resectability: PREDICT classification.\",\"authors\":\"Noriko Matsuura, Motohiko Kato, Kentaro Iwata, Kurato Miyazaki, Teppei Masunaga, Yoko Kubosawa, Mari Mizutani, Yukie Hayashi, Kaoru Takabayashi, Yusaku Takatori, Atsushi Nakayama, Koji Okabayashi, Hirofumi Kawakubo, Yuko Kitagawa, Naohisa Yahagi\",\"doi\":\"10.1055/a-2387-1754\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background and study aims</b> The safety of endoscopic submucosal dissection (ESD) has been reported, and the risk of lymph node metastasis is low for colorectal cancer if depth of invasion is the only non-curative factor on histological evaluation. ESD is increasingly performed even if submucosal (SM) invasion is suspected. However, reports about endoscopic findings for the criteria to predict ESD resectability remain limited. Endoscopic ultrasound (EUS) can directly visualize the tomographic image of the gastrointestinal wall and may help predict ESD resectability. Therefore, we investigated the possibility of predicting ESD resectability using EUS. <b>Patients and methods</b> We compared the association between EUS findings and pathological results for gastric or colorectal lesions with suspected SM invasion using white light endoscopy between June 2020 and January 2023. EUS findings were grouped based on the status of the underlying the tumor, as follows: Type I, submucosal layer was observed with reproducibility; Type II, submucosal layer not fully visible; and Type III, submucosal layer disrupted and muscularis propria (MP) layer thickened. <b>Results</b> Forty-one gastric cancer and 22 colorectal cancer cases were analyzed. The proportions of pathological VM0 (no tumor exposed on any vertical margin) for ESD-resected specimens were 89% and 33% for Type I and II, respectively, ( <i>P</i> ≤ 0.01). The proportions of cancer involving MP or deeper were significantly higher for Type II/III than for Type I (41% vs 0%, <i>P</i> ≤ 0.01). <b>Conclusions</b> EUS may have an important role in predicting ESD resectability of gastric and colorectal cancers suspected of having SM invasion.</p>\",\"PeriodicalId\":11671,\"journal\":{\"name\":\"Endoscopy International Open\",\"volume\":\"12 9\",\"pages\":\"E1075-E1084\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11405118/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endoscopy International Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2387-1754\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endoscopy International Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2387-1754","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和研究目的 据报道,内镜粘膜下剥离术(ESD)的安全性很高,而且如果侵犯深度是组织学评估中唯一的非治愈因素,那么结直肠癌淋巴结转移的风险很低。即使怀疑有粘膜下(SM)侵犯,也越来越多地进行ESD。然而,有关预测ESD可切除性标准的内镜检查结果的报道仍然有限。内镜超声(EUS)可直接观察胃肠壁的断层图像,有助于预测ESD的可切除性。因此,我们研究了使用 EUS 预测 ESD 可切除性的可能性。患者和方法 我们比较了 2020 年 6 月至 2023 年 1 月期间使用白光内镜检查疑似 SM 侵犯的胃或结直肠病变的 EUS 结果与病理结果之间的关联。根据肿瘤底层的状态将 EUS 结果分组如下:I型,粘膜下层被观察到,具有可重复性;II型,粘膜下层不完全可见;III型,粘膜下层被破坏,固有肌层(MP)增厚。结果 分析了 41 例胃癌和 22 例结直肠癌病例。ESD切除标本的病理VM0(任何垂直边缘无肿瘤暴露)比例在I型和II型中分别为89%和33%(P≤0.01)。II/III 型涉及 MP 或更深的癌症比例明显高于 I 型(41% vs 0%,P ≤ 0.01)。结论 EUS 可在预测疑似 SM 侵犯的胃癌和结直肠癌的 ESD 可切除性方面发挥重要作用。
Endoscopic ultrasound classification for prediction of endoscopic submucosal dissection resectability: PREDICT classification.
Background and study aims The safety of endoscopic submucosal dissection (ESD) has been reported, and the risk of lymph node metastasis is low for colorectal cancer if depth of invasion is the only non-curative factor on histological evaluation. ESD is increasingly performed even if submucosal (SM) invasion is suspected. However, reports about endoscopic findings for the criteria to predict ESD resectability remain limited. Endoscopic ultrasound (EUS) can directly visualize the tomographic image of the gastrointestinal wall and may help predict ESD resectability. Therefore, we investigated the possibility of predicting ESD resectability using EUS. Patients and methods We compared the association between EUS findings and pathological results for gastric or colorectal lesions with suspected SM invasion using white light endoscopy between June 2020 and January 2023. EUS findings were grouped based on the status of the underlying the tumor, as follows: Type I, submucosal layer was observed with reproducibility; Type II, submucosal layer not fully visible; and Type III, submucosal layer disrupted and muscularis propria (MP) layer thickened. Results Forty-one gastric cancer and 22 colorectal cancer cases were analyzed. The proportions of pathological VM0 (no tumor exposed on any vertical margin) for ESD-resected specimens were 89% and 33% for Type I and II, respectively, ( P ≤ 0.01). The proportions of cancer involving MP or deeper were significantly higher for Type II/III than for Type I (41% vs 0%, P ≤ 0.01). Conclusions EUS may have an important role in predicting ESD resectability of gastric and colorectal cancers suspected of having SM invasion.